Atossa Therapeutics (ATOS) Earnings Date & Reports

Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

ATOS is expected to report earnings to fall 2.70% to -108 cents per share on August 17

Atossa Therapeutics ATOS Stock Earnings Reports

Q2'26

Est.

$-1.08

Q1'26

Missed

by $1.04

Q4'25

Missed

by $1.20

Q3'25

Missed

by $0.01

Q2'25

Missed

by $0.01

The last earnings report on May 08 showed earnings per share of -111 cents, missing the estimate of -7 cents. With 215.87K shares outstanding, the current market capitalization sits at 18.25M.

View a ticker or compare two or three

Compare

ATOS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ATOS